TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview
Description
Tol-like receptor (TLR) agonists, as potent adjuvants, have gained attention in vaccine research for their ability to enhance immune responses. This study focuses on their application in improving vaccine efficacy against key viral infections
